Market research
IMR.AU Imricor Medical Systems, Inc
AU AUD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4B
- P/E ratio
- Not available
- Analyst target
- 2.9529
- Dividend yield
- Not available
- Beta
- 0.54
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU0000054942
- Market cap
- 4B
- P/E ratio
- Not available
- Analyst target
- 2.9529
- Dividend yield
- Not available
- Beta
- 0.54
About
About Imricor Medical Systems, Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Research context
Imricor Medical Systems, Inc appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the IMR.AU discussion.
5 years, 6 months ago
Imricor Medical Systems, Inc is currently in a long term downtrend where the price is trading 14.3% below its 200 day moving average.
From a valuation standpoint, the stock is 3.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 247.7.
Imricor Medical Systems, Inc's total revenue sank by 27.4% to $425K since the same quarter in the previous year.
Its net income has increased by 19.3% to $-7M since the same quarter in the previous year.
Finally, its free cash flow fell by 85.0% to $-4M since the same quarter in the previous year.
Based on the above factors, Imricor Medical Systems, Inc gets an overall score of 2/5.